Related Experiment Video
Updated: Dec 16, 2025

Application of Consistent Massage-Like Perturbations on Mouse Calves and Monitoring the Resulting Intramuscular Pressure Changes
Published on: September 20, 2019
[Non-inflammatory muscle pain]
This article reviews non-inflammatory causes of muscle pain, differentiating between focal and diffuse types. It highlights statin side effects, myotonias, metabolic myopathies, and fibromyalgia syndrome (FMS) for differential diagnosis.
Area of Science:
- Neurology
- Rheumatology
- Genetics
Background:
- Muscle pain is a common symptom in clinical practice, often presenting as a non-specific sign of various internal and neurological conditions.
- While inflammatory and autoimmune muscular diseases are primary causes, non-inflammatory etiologies require careful differential diagnosis.
Observation:
- The article distinguishes between focal and diffuse muscle pain, emphasizing that muscle biopsy is a last resort diagnostic step.
- Non-inflammatory causes discussed include statin-induced myopathies (rhabdomyolysis, atrophy, necrosis), inherited myotonias, and metabolic myopathies affecting carbohydrate, fat, or purine metabolism.
Findings:
- Fibromyalgia syndrome (FMS) is presented as a non-inflammatory condition, understood through a biopsychosocial model.
- Diagnostic tools like the Widespread Pain Index (WPI) and Symptom Severity Scale (SSS) aid in identifying FMS by assessing pain regions and core symptoms such as fatigue and sleep disturbances.
Implications:
- Understanding these diverse non-inflammatory causes is crucial for accurate diagnosis and effective management of muscle pain.
- This review provides a framework for clinicians to navigate differential diagnoses beyond primary inflammatory muscle diseases.
- The use of validated questionnaires can streamline the diagnosis of complex conditions like FMS.
Related Concept Videos
Skeletal Muscle Relaxants: Therapeutic Uses
Classification of Skeletal Muscle Relaxants
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Centrally Acting Muscle Relaxants: Therapeutic Uses
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Peripherally and Centrally Acting Muscle Relaxants: A Comparison
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
Skeletal Muscle Relaxants: Adverse Effects
Unlike...

